Names and pronunciation
(pom–a-lid′oh-mide) Pomalyst
PDF page 1063
Loading InternPractice…
Drug reference
(pom–a-lid′oh-mide) Pomalyst
PDF page 1063
Func. class.: Antineoplastic, biologic response modifier, hormone
PDF page 1063
Chem. class.: TNF modifier
PDF page 1063
USES: Multiple myeloma in those who have received ≥2 treatments including lenalidomide and bortezomib and disease has progressed within 60 days of completion of the treatment or in BRAF V600 mutation-positive patients who have disease progression following ipilimumab and a BRAF inhibitor
PDF page 1063
CONTRAINDICATIONS: Breast feeding, hypersensitivity
PDF page 1063
Black Box Warning: Pregnancy, throm- bocytopenia
PDF page 1063
DOSAGE AND ROUTES • Adult: PO 4 mg on days 1-21, repeat in 28-day cycles Hepatic/renal dose • Adult: PO bilirubin >2 mg/dL and AST/ ALT >3 × ULN or CCr >3 mg/dL, do not use
PDF page 1063
Available forms: Capsule 1, 2, 3, 4 mg
PDF page 1063
• Adult: PO 4 mg on days 1-21, repeat in 28-day cycles Hepatic/renal dose
PDF page 1063
• Adult: PO bilirubin >2 mg/dL and AST/ ALT >3 × ULN or CCr >3 mg/dL, do not use
PDF page 1063